9th Apr 2009 17:17
|
For immediate release |
9 April 2009 |
TYRATECH, INC.
("TyraTech" or "The Company")
DIRECTOR SHARE DEALINGS
TyraTech Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, announces that it was informed on 8 April, 2009 that Douglas Armstrong, Chief Executive Officer, sold 1,000 common shares in TyraTech at $0.15 per share on 8 April 2009. The share sale was carried out as part of his 2008 tax position. As a result of the transaction, Dr Armstrong now holds 542,059 common shares (representing 2.5% of the issued share capital).
For further information, please contact:
|
TyraTech Inc. |
|
|
Keith Bigsby, Chief Financial Officer |
+1 (321) 409 7714 |
|
www.tyratech.com |
|
|
Nomura Code Securities |
+44 (0)20 7776 1200 |
|
Charles Walker/Clare Terlouw |
|
|
www.nomuracode.com |
|
|
Buchanan Communications |
+44 (0)20 7466 5000 |
|
Mary-Jane Elliott/Lisa Baderoon/ Catherine Breen/Stasa Filiplic |
|
|
www.buchanan.uk.com |
NOTES TO EDITORS
About TyraTech
TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.
TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.
TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.
Related Shares:
Tyratech